Predictive utility of circulating methylated DNA in serum of melanoma patients receiving biochemotherapy. - Wikidata - wikimedia - TriplyDB

Predictive utility of circulating methylated DNA in serum of melanoma patients receiving biochemotherapy.

Predictive utility of circulating methylated DNA in serum of melanoma patients receiving biochemotherapy.

http://www.wikidata.org/entity/Q33796956

about

Methylated circulating tumor DNA in blood: power in cancer prognosis and response DNA hybridization detection with 100 zM sensitivity using piezoelectric plate sensors with an improved noise-reduction algorithm.Epigenetic regulation in human melanoma: past and future Emerging technologies for studying DNA methylation for the molecular diagnosis of cancer Whole blood DNA aberrant methylation in pancreatic adenocarcinoma shows association with the course of the disease: a pilot study Association of circulating tumor cells with serum tumor-related methylated DNA in peripheral blood of melanoma patients Estrogen receptor-alpha methylation predicts melanoma progression Epigenetics of human cutaneous melanoma: setting the stage for new therapeutic strategies A phase 1 and pharmacodynamic study of decitabine in combination with carboplatin in patients with recurrent, platinum-resistant, epithelial ovarian cancer DNA methylation and gene deletion analysis of brain metastases in melanoma patients identifies mutually exclusive molecular alterations Multiparametric analysis of cell-free DNA in melanoma patients Aberrant DNA methylation in malignant melanoma Aberrant DNA hypermethylation patterns lead to transcriptional silencing of tumor suppressor genes in UVB-exposed skin and UVB-induced skin tumors of mice.Methylome analysis identifies a Wilms tumor epigenetic biomarker detectable in blood.Methylation levels of the "long interspersed nucleotide element-1" repetitive sequences predict survival of melanoma patients AIM1 and LINE-1 epigenetic aberrations in tumor and serum relate to melanoma progression and disease outcome Aberrant hypermethylation in primary tumours and sentinel lymph node metastases in paediatric patients with cutaneous melanoma.Epigenetic biomarkers in skin cancer.The relationship between RASSF1A gene promoter methylation and the susceptibility and prognosis of melanoma: A meta-analysis and bioinformatics Effectiveness of circulating tumor DNA for detection of KRAS gene mutations in colorectal cancer patients: a meta-analysis.Tumor-Related Methylated Cell-Free DNA and Circulating Tumor Cells in Melanoma.Circulating Tumor Cells, DNA, and mRNA: Potential for Clinical Utility in Patients With Melanoma.RASSF8 regulates progression of cutaneous melanoma through nuclear factor-κb.Prognostic molecular biomarkers for cutaneous malignant melanoma RASSF1A hypermethylation in pretreatment serum DNA of neuroblastoma patients: a prognostic marker.The context and potential of epigenetics in oncology CpG island hypermethylation profile in the serum of men with clinically localized and hormone refractory metastatic prostate cancer.CpG island methylator phenotype predicts progression of malignant melanoma DNA methylation in circulating tumour DNA as a biomarker for cancer.Utility of circulating B-RAF DNA mutation in serum for monitoring melanoma patients receiving biochemotherapy Minireview: epigenetic changes in ovarian cancer.Cancer Cells Expressing Toll-like Receptors and the Tumor Microenvironment.Epigenetics in human melanoma.Liquid Biopsies for Assessing Metastatic Melanoma Progression.Clinical relevance of cell-free DNA in gastrointestinal tract malignancy Aberrant DNA methylation in melanoma: biomarker and therapeutic opportunities.Circulating tumor cells in uveal melanoma.Blood biomarkers for uveal melanoma.Methylation of tumor suppressor microRNAs: lessons from lymphoid malignancies.Diagnostic and prognostic value of circulating tumor-related DNA in cancer patients.

P2860

Q26772077-6B85F204-238E-4219-8DDE-AF79E3C1F70D Q27336155-09E6961F-9E6B-4522-84A2-3FC42F756950 Q28085681-284391F6-4C9D-41F5-A865-DD662533A9EE Q28087759-46C934BA-D2DE-4F72-9E8B-441A6E1A353F Q28729757-F41B44D1-B0CD-49ED-9B60-11BFCC865B72 Q33797039-97B8E7F8-CB17-4E60-965F-20ACE8ECC8D2 Q33797076-1121436E-1E9D-441B-AFB0-0167C61DC99F Q33980682-7066F0A0-65FF-4CDC-9FAA-4F617E73422E Q34091420-F6EB4B3E-A512-4014-9A92-E78A7C04A3B7 Q34359695-30C0C66D-FEF8-4424-8CD5-476384EEB5F4 Q34499759-76B84CBA-3D03-4B43-86DB-519EF6A0FFCA Q34516587-5BA97D8F-690A-4D8B-AD05-59C2B1B217A4 Q34734084-33F1B315-6579-4089-ACB2-F587FEDE8755 Q35027111-19B76F8B-3720-47B8-8DB4-058C6399FC03 Q35069309-CAA8D4F6-4048-4491-9CBD-D5A2158E4ECA Q35962455-BA21FF89-E44A-4959-88DD-23DF22A0FB8D Q35989635-10030C14-4075-4237-9F17-834F1C6F3FB0 Q36080974-40886688-8958-4B99-BD23-2D5402E0D0A5 Q36282768-53F2D8D3-0D5C-4F92-9BEA-02D849871868 Q36292534-759CA0DE-7B9B-4AA5-86CF-F58D30B96F2B Q36443927-1164AC39-780B-4371-B2AD-20079C4FC182 Q36452245-B11B582E-505E-4DE1-8473-0B1FF36BB4B6 Q36557527-D25220C7-2207-4AE1-AB41-8BB6CE51DF78 Q36905877-038109A5-FD58-4133-BA13-3E1ABE01BD24 Q37081084-2C83A34B-71C0-4AF6-980C-FBEC98AEC05E Q37123413-D3DA0DA2-352E-4E7F-A82B-3B566BBC5712 Q37243155-7C29ACA5-F79A-47E1-BE69-E62A9135D593 Q37245444-1B2ADBAD-2136-4517-B1CA-37C9F8141C59 Q37280956-99C2B810-7754-4CF6-BAB7-ED06E3A37B9C Q37286893-6FC91DD6-1A26-43B1-B107-B52BA9C75FE1 Q37328836-C6A6ED99-0FE6-48EC-93D9-B469E45298EA Q37373357-88C20B40-1FB8-4A89-8679-F3B97A702952 Q37531849-5F8099F6-030C-48BB-B35D-E11F017CF068 Q37667080-F767D5D9-99A1-4792-87F6-E683026EE190 Q37709415-892158F3-0CF8-4E27-AABD-10D161B40721 Q37737945-0AA20703-B796-4A03-9DA9-796DD2BE327E Q37822739-BCE4F55E-32D5-40FE-A4FA-8E4077A6C4C1 Q37984126-A422DFCF-0081-4174-A0D4-A86EDAE38B63 Q38059899-203BE71C-B7C9-40C6-96D9-F7EEDC6BBD87 Q38152782-1BEB52C1-B947-4F2D-912A-E5918B0561AF

P2860

Predictive utility of circulating methylated DNA in serum of melanoma patients receiving biochemotherapy.

http://www.wikidata.org/entity/Q33796956

description

2005 nî lūn-bûn

@nan

2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Predictive utility of circulat ...... nts receiving biochemotherapy.

@ast

Predictive utility of circulat ...... nts receiving biochemotherapy.

@en

type

label

Predictive utility of circulat ...... nts receiving biochemotherapy.

@ast

Predictive utility of circulat ...... nts receiving biochemotherapy.

@en

prefLabel

Predictive utility of circulat ...... nts receiving biochemotherapy.

@ast

Predictive utility of circulat ...... nts receiving biochemotherapy.

@en

P1433

Q33796956-2DA9579F-B115-4BEC-81CC-D42C564724E2

P1476

Q33796956-E9E182BA-6CFB-4ECD-8B79-FEBE8FB6ADDA

P2093

Q33796956-0813076D-6C1F-45D2-8A49-6B913CEEF47B

Q33796956-18A7577E-B0A7-43F7-A326-D59A36229DB9

Q33796956-19E7E31D-AE1A-476C-839A-A002B41738DF

Q33796956-331C9C89-5263-4992-B3ED-640F466E38A6

Q33796956-38D0CF4B-002A-4A93-9082-C4109C256529

Q33796956-653AF93C-6CE6-495E-A6C0-D695AD78B3C1

Q33796956-700911C3-DA77-4E37-8A44-738E648830EC

Q33796956-8C586FE8-5D1D-403C-88B7-2648FA64FA7F

Q33796956-977DEB47-C219-4B7A-9F5F-C334D5A8D80D

Q33796956-B14D6708-4448-4E19-A9D4-8B92EAB9F57F

P2860

Q33796956-005A9760-EEA6-47DC-BEDF-D60A32C62BC1

Q33796956-0253622D-34DE-445E-8467-421D34FAF9E6

Q33796956-07600878-A811-4031-AF7C-F8E912B08F3B

Q33796956-15DAABC8-C15C-42A3-B0A1-F4B18037EB24

Q33796956-1FC5B791-CF65-4B67-885F-13353AA9677A

Q33796956-21D86E44-9FAF-4325-B5F4-23895BE155AE

Q33796956-22B149AB-6584-4283-944E-523499061852

Q33796956-22DACE6F-88D0-4CF1-8F32-1E2BD4658581

Q33796956-27992F81-74F0-4618-A568-D989BF661992

Q33796956-27BDE060-4C6D-47A3-8893-8F932EC49015

P304

Q33796956-4306946E-7C46-4536-B890-079F326E92FB

P31

Q33796956-DC5FF06B-3F61-4623-A59C-EB8578A09E87

P356

Q33796956-762532CB-D2A0-4F36-820E-F21D99DEF45A

P407

Q33796956-DE44C803-4A2F-4099-9F23-82F06EDA8C19

P433

Q33796956-13DB68E8-FB73-4978-BF38-A4B6CFC12928

P478

Q33796956-693616DF-A381-428D-A0E6-2FE5DDEA5555

P50

Q33796956-C0538657-47AD-4BAE-AF41-C44A099BC62F

P577

Q33796956-598FB778-0EFC-4EDC-8405-2748F503A5CB

P698

Q33796956-83433249-D218-4C37-9E2C-42FB93CFA606

P932

Q33796956-D96AF0C5-8CA3-42F6-A9BE-05ECA98432F4

P356

JCO.2005.02.9876

P1433

Journal of Clinical Oncology

P1476

Predictive utility of circulat ...... ents receiving biochemotherapy

@en

P2093

Christine Kuo

http://www.w3.org/2001/XMLSchema#string

He-Jing Wang

http://www.w3.org/2001/XMLSchema#string

Kazuo Koyanagi

http://www.w3.org/2001/XMLSchema#string

Minoru Kitago

http://www.w3.org/2001/XMLSchema#string

Naoyuki Umetani

http://www.w3.org/2001/XMLSchema#string

Robert Milford

http://www.w3.org/2001/XMLSchema#string

Sandy L Nguyen

http://www.w3.org/2001/XMLSchema#string

Steve R Martinez

http://www.w3.org/2001/XMLSchema#string

Steven J O'Day

http://www.w3.org/2001/XMLSchema#string

Takuji Mori

http://www.w3.org/2001/XMLSchema#string

P2860

The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation.

Role of promoter hypermethylation in Cisplatin treatment response of male germ cell tumors

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents.

The fundamental role of epigenetic events in cancer

Gene silencing in cancer in association with promoter hypermethylation

Emerging molecular markers of cancer.

The gene expression signatures of melanoma progression

Detection and quantitation of human papillomavirus (HPV) DNA in the sera of patients with HPV-associated head and neck squamous cell carcinoma.

Maintenance biotherapy for metastatic melanoma with interleukin-2 and granulocyte macrophage-colony stimulating factor improves survival for patients responding to induction concurrent biochemotherapy.

DNA hypermethylation in tumorigenesis: epigenetics joins genetics.

P304

9351-9358

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2005.02.9876

http://www.w3.org/2001/XMLSchema#string

P407

P433

36

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P50

P577

2005-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16361635

http://www.w3.org/2001/XMLSchema#string

P932

2856438

http://www.w3.org/2001/XMLSchema#string